By Lisa Kerner
Charlotte, N.C., June 28 - Dune Medical Devices, Ltd. said it closed a $12.5 million round of series B funding.
Proceeds will be used to complete pivotal clinical studies of Dune's BP probe and console system, attain market clearance of the BP system by the Food and Drug Administration, start development of the company's second product and expand Dune's U.S. infrastructure.
Apax Partners led the round as well as two previous tranched $7.5 million series A rounds.
Located in Ceasarea, Israel, Dune is a privately owned venture-funded medical device company.
| Issuer: | Dune Medical Devices, Ltd.
|
| Issue: | Series B funding
|
| Amount: | $12.5 million
|
| Investor: | Apax Partners
|
| Announcement date: | June 28
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
